Clinical Trials List
Protocol NumberPTC124-GD-041-DMD
Completed
2017-09-01 - 2023-12-29
Phase III
Terminated2
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 王麗君 Division of Pediatrics
- WEN-CHIN WENG Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chen Liang Division of Pediatrics
- 徐仲豪 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11~16 participants
-
Global
340 participants
